Exploring Promising Therapies for Non-Alcoholic Fatty Liver Disease: A ClinicalTrials. gov Analysis
Background Non-alcoholic fatty liver disease (NAFLD) is a common disease and has been
increasing in recent years. To date, no FDA-approved drug specifically targets NAFLD …
increasing in recent years. To date, no FDA-approved drug specifically targets NAFLD …
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions
MMI Abdalla - Therapeutic Advances in Endocrinology and …, 2024 - journals.sagepub.com
Adiponectin, an adipose-derived hormone, plays a pivotal role in glucose regulation and
lipid metabolism, with a decrease in circulating adiponectin levels being linked to insulin …
lipid metabolism, with a decrease in circulating adiponectin levels being linked to insulin …
Effect of phenylbutazone on insulin secretion in horses with insulin dysregulation
KL Kemp, JE Skinner, FR Bertin - Journal of Veterinary Internal …, 2024 - Wiley Online Library
Background Phenylbutazone is often prescribed to manage pain caused by
hyperinsulinemia‐associated laminitis, but in diabetic people nonsteroidal anti‐inflammatory …
hyperinsulinemia‐associated laminitis, but in diabetic people nonsteroidal anti‐inflammatory …